References and Notes
1a
Helmchen G.
Dahnz A.
Dübon P.
Schelwies M.
Weihofen R.
Chem. Commun.
2007,
675
1b
Takeuchi R.
Kezuka S.
Synthesis
2006,
3349
2a
Feringa BL.
Acc. Chem. Res.
2000,
33:
346
2b
Tissot-Croset K.
Polet D.
Gille S.
Hawner C.
Alexakis A.
Synthesis
2004,
2586
3a
Bartels B.
Helmchen G.
Chem. Commun.
1999,
741
3b
Bartels B.
Garcia-Yebra C.
Rominger F.
Helmchen G.
Eur. J. Inorg. Chem.
2002,
2569
3c
Lipowsky G.
Miller N.
Helmchen G.
Angew. Chem. Int. Ed.
2004,
43:
4595 ; Angew. Chem.
2004, 116, 4695
3d
Streiff S.
Welter C.
Schelwies M.
Lipowsky G.
Miller N.
Helmchen G.
Chem. Commun.
2005,
2957
3e
Polet D.
Alexakis A.
Tissot-Croset K.
Corminboeuf C.
Ditrich K.
Chem. Eur. J.
2006,
12:
3596 ; and references cited therein
4a
Ohmura T.
Hartwig JF.
J. Am. Chem. Soc.
2002,
122:
15164
4b
Welter C.
Koch O.
Lipowsky G.
Helmchen G.
Chem. Commun.
2004,
896
4c
Leitner A.
Shu C.
Hartwig JF.
Org. Lett.
2005,
7:
1093 ; and references cited therein
4d
Polet D.
Alexakis A.
Org. Lett.
2005,
7:
1621 ; and references cited therein
4e
Weihofen R.
Dahnz A.
Tverskoy O.
Helmchen G.
Chem. Commun.
2005,
3541
5a
López F.
Ohmura T.
Hartwig JF.
J. Am. Chem. Soc.
2003,
125:
3426
5b
Shu C.
Hartwig JF.
Angew. Chem. Int. Ed.
2004,
43:
4794 ; Angew. Chem. 2004, 116, 4898
6
Kiener CA.
Shu C.
Incarvito C.
Hartwig JF.
J. Am. Chem. Soc.
2003,
125:
14272
7a
Dai L.-X.
Tu T.
You S.-L.
Deng W.-P.
Hou X.-L.
Acc. Chem. Res.
2003,
36:
659
7b
Trost BM.
Jiang C.
Org. Lett.
2003,
5:
1563 ; and references cited therein
8a
Weihofen R.
Tverskoy O.
Helmchen G.
Angew. Chem. Int. Ed.
2006,
45:
5546 ; Angew. Chem. 2006, 118, 5673
8b
Dahnz A.
Helmchen G.
Synlett
2006,
697
9
Tsuji J.
Shimizu I.
Minami I.
Ohashi Y.
Tetrahedron Lett.
1982,
23:
4809
10
Ishibashi F.
Taniguchi E.
Bull. Chem. Soc. Jpn.
1988,
61:
4361
11a
Stork G.
Niu D.
Fujimoto A.
Koft ER.
Balkovec JM.
Tata JR.
Dake GR.
J. Am. Chem. Soc.
2001,
123:
3239
11b
Raheem IT.
Goodman SN.
Jacobsen EN.
J. Am. Chem. Soc.
2004,
126:
706
12
General Procedure for the Ir-Catalyzed Allylic Alkylation under Salt-Free Conditions
Under argon, a solution of [Ir(COD)Cl]2 (13.4 mg, 0.02 mmol) and L* (0.04 mmol) in anhyd THF (1.0 mL, content of H2O <30 mg/L, Karl-Fischer titration) was treated with anhyd 1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD, 11.1 mg, 0.08 mmol) and stirred for 5 min (L2) or 2 h (L1, L3).
Then, carbonate 1 (1.0 mmol), anhyd THF (4 mL) and the pronucleophile (1.4 mmol) were added, and the solution was stirred for the time and at the temperature stated in Table
[1]
. Conversion was monitored by TLC or GC. The solvent was removed under reduced pressure and the residue was analyzed with respect to the ratio of branched and linear product by 1H NMR. Pure reaction products were obtained by flash column chromatography.
13
Analytical Data for (+)-(
R
)-Dimethyl {1-[(Trityl-oxy)methyl]prop-2-en-1-yl}malonate (2c)
Oil; [α]D
20 +38.9 (c 0.99, CHCl3; 99.5% ee (R)]. 1H NMR (300 MHz, CDCl3): δ = 3.05-3.25 (m, 3 H, OCH2CH, OCH2), 3.61, 3.67 (2 s, 6 H, OCH3), 3.84 [d, J = 8.4 Hz, 1 H, CH(CO2CH3)2], 5.14 (d, J = 8.4, 1 H, CH=CH
EHZ), 5.16 (d, J = 17.3 Hz, 1 H, CH=CHE
H
Z), 5.94 (ddd, J = 17.1, 10.3, 8.8 Hz, 1 H, CH=CH2), 7.25-7.34 (m, 9 H, Ph), 7.41-7.44 (m, 6 H, Ph). 13C NMR (75 MHz, CDCl3): δ = 44.46 (d, OCH2
CH), 52.22, 52.34 (2 s, OCH3), 53.29 [d, CH(CO2CH3)2], 64.25 (t, OCH2), 86.68 (s, CPh3), 118.01 (t, CH=CH2), 126.97, 127.73, 128.68 (3 d, Ph), 135.67 (d, CH=CH2), 143.78 (s, Ph), 168.53, 168.62 (2 s, CO2CH3). Anal. Calcd for C28H28O5: C, 75.65; H, 6.35. Found: C, 75.52; H, 6.56. HRMS-FAB: m/z calcd for C28H27O5
[M - H]+: 443.1858; found: 443.1838.
14
Synthesis of (+)-(
S
)-Methyl 3-[(Trityloxy)methyl]pent-4-enoate (2c′)
A suspension of (+)-(R)-2c (2.23 g, 5.01 mmol), NaCl (0.44 g, 7.52 mmol) and H2O (0.56 mL, 31.06 mmol) in DMSO (8.2 mL) was stirred for 22 h at 160 °C. Then, the reaction mixture was cooled to r.t., diluted with H2O (45 mL), and the aqueous layer was extracted with Et2O (3 × 90 mL). The organic layers were combined, washed with brine (45 mL), dried over Na2SO4 and concentrated under reduced pressure. The crude product was purified by flash column chromatog-raphy.
HPLC Data for 2c′
Daicel Chiralcel AD-H, 250 × 4.6 mm, 5 µm, with guard cartridge 10 × 4 mm, 5 µm, n-hexane-i-PrOH 98:2, flow = 0.5 mL min-1, r.t., 210 nm: t
R[(+)-(S)-2c′] = 13 min, t
R[(-)-(R)-2c′] = 18 min.
Analytical Data for (+)-(
S
)-(2c′)
Oil; [α]D
20 +12.9 [c 1.00, CHCl3; >99% ee (S)]. 1H NMR (300 MHz, CDCl3): δ = 2.37 (dd, J = 15.0, 8.2 Hz, 1 H, CH
aHbCO2CH3), 2.67 (dd, J = 15.3, 5.9 Hz, 1 H, CHa
H
bCO2CH3), 2.82-2.96 (m, 1 H, CHCH2O), 3.03 (dd, J = 8.7, 6.9 Hz, 1 H, CH
aHbO), 3.16 (dd, J = 8.8, 5.3 Hz, 1 H, CHa
H
bO), 3.63 (s, 3 H, OCH3), 5.06 (ddd, J = 10.3, 1.4, 0.9 Hz, 1 H, CH=CH
EHZ), 5.09 (ddd, J = 17.2, 1.4, 1.3 Hz, 1 H, CH=CHE
H
Z), 5.78 (ddd, J = 17.4, 10.1, 7.4 Hz, 1 H, CH=CH2), 7.20-7.37 (m, 9 H, Ph), 7.39-7.50 (m, 6 H, Ph). 13C NMR (75 MHz, CDCl3): δ = 36.58 (t, CH2CO2CH3), 40.68 (d, CHCH2O), 51.42 (q, OCH3), 65.91 (t, CH2O), 86.49 (s, CPh3), 116.05 (t, CH=CH2), 126.93, 127.72, 128.70 (3 d, Ph), 138.22 (d, CH=CH2), 144.05 (s, Ph), 172.91 (s, CO2CH3). Anal. Calcd for C26H26O3: C, 80.80; H, 6.78. Found: C, 80.50; H, 6.82. HRMS-FAB: m/z calcd for C26H26O3Na [M + Na]+: 409.1779; found: 409.1784.
15
Synthesis of the Taniguchi Lactone (+)-(
S
)-(4)
ZnCl2 (0.71 g, 5.15 mmol) was added to a solution of (+)-(S)-2c′ (1.89 g, 4.90 mmol) in CH2Cl2 (10 mL). The suspension was stirred at r.t. for 15 h. Phosphate buffer (pH 7, 100 mL) was added and the aqueous layer was extracted with Et2O (3 × 100 mL). The organic layers were combined, dried over Na2SO4 and concentrated under reduced pressure. The crude product was purified by flash column chromatog-raphy.
GC Data for 4
Chrompack permethyl-β-cyclodextrin, 25 m × 0.25 mm, temperature program: 70 °C (20 min), then gradient 10 °C/min (11 min), then 180 °C (10 min), injector temperature 200 °C: t
R [(+)-(S)-4] = 27.0 min, t
R [(-)-(R)-4] = 27.1 min.
Analytical Data for (+)-(
S
)-4
Colorless oil; [α]D
20 +7.6 [c 1.10, EtOH, >99% ee (S)]. 1H NMR (250 MHz, CDCl3): δ = 2.35 (dd, J = 17.2, 8.9 Hz, 1 H, CH
aHbCO2), 2.64 (dd, J = 17.4, 8.2 Hz, 1 H, CHa
H
bCO2), 3.07-3.30 (m, 1 H, CH), 3.98 (dd, J = 8.4, 8.4 Hz, 1 H, CH
a
HbO), 4.40 (dd, J = 8.4, 8.2 Hz, 1 H, CHa
H
bO), 5.13 (d, J = 10.1 Hz, 1 H, CH=CH
EHZ), 5.15 (d, J = 17.1 Hz, 1 H, CH=CHE
H
Z), 5.74 (ddd, J = 17.3, 9.9, 7.5 Hz, 1 H, CH=CH2). 13C NMR (75 MHz, CDCl3): δ = 34.04 (d, CH), 39.69 (t, CH2CO2), 72.11 (t, CH2O), 117.35 (t, CH=CH2), 135.72 (d, CH=CH2), 176.35 (s, CO2). HRMS (EI): m/z calcd for C6H8O2 [M]+: 112.0524; found: 112.0523.
16
HPLC and GC Data for 2 and 3 (Table 1)
HPLC (Daicel columns, 250 × 4.6 mm, 5 µm with guard cartridge, 10 × 4 mm, 0.5 mL min-1): 2a (Chiralcel OJ-H, n-hexane-i-PrOH 97:3, r.t., 210 nm) t
R[(-)-(S)-2a] = 58 min, t
R[(+)-(R)-2a] = 64 min; 2b (Chiralcel AD-H, n-hexane-i-PrOH 99:1, 20 °C, 220 nm) t
R[(+)-(R)-2b] = 12 min, t
R[(-)-(S)-2b] = 14 min, t
R[3b] = 15 min; 2c (Chiralcel OD-H, n-hexane-i-PrOH 98:2, 20 °C, 210 nm) t
R[(+)-(R)-2c] = 16 min, t
R[(-)-(S)-2c] = 19 min, t
R[3c] = 22 min.
GC [Chiraldex γ-Trifluoroacetyl (G-TA), 30 m × 0.25 mm × 0.125 µm, 50-100 °C, 1 °C/min, injector temperature 200 °C, detector temperature 250 °C]: t
R[(+)-(R)-2d] = 33 min, t
R[(-)-(S)-2d] = 34 min.
17 Product 5a was obtained as a ca. 2:1 mixture of diastereomers, which were not individually characterized.
18
HPLC Data for 5 (Table 2)
For 5a determined after demethoxycarbonylation to give (S)-3-({[tert-butyl(diphenyl)silyl]oxy}methyl)pent-4-enenitrile (5a′).
Daicel Chiralcel OD-H, 250 × 4.6 mm, 5 µm, with guard cartridge 10 × 4 mm, 5 µm, n-hexane-i-PrOH 99:1, flow = 0.5 mL min-1, 20 °C, 210 nm: t
R[(-)-(R)-5′a] = 15 min, t
R[(+)-(S)-5′a] = 24 min; t
R[(-)-(S)-5b] = 18 min, t
R[(+)-(R)-5b] = 22 min.4b
19
Procedure for the Ir-Catalyzed Cyclization According to Scheme 6
The catalyst solution was prepared as described above12 and was diluted with anhyd THF (4 mL).
(a) Preparation of 8a
The solution of the catalyst was cooled to the temperature stated in Table 3 and carbonate 7a (0.5 mmol) was added through a septum with a syringe. Conversion was monitored by TLC or GC. When conversion was complete or no further conversion was detected, Et2O (5 mL) and sat. NH4Cl solution (5 mL) were added without warming, and the mixture was extracted with Et2O (2 × 20 mL). The combined organic phases were washed with brine (20 mL), dried over Na2SO4 and concentrated under reduced pressure. The crude product was purified by flash column chromatography.
As the reaction is reversible, work-up has to be started at low temperature by adding aq NH4Cl solution. In order to prove reversibility, an enantiomerically enriched sample of (R)-7a (91% ee) was treated at r.t. according to the general procedure with ent-L2. In doing so, the ee decreased to 39% (R) within 19 h.
(b) Preparation of 8b
Carbonate 7b (0.5 mmol) was added to the catalyst solution prepared as described above, and the reaction mixture was stirred for the time stated in Table 3. For work-up, the mixture was concentrated under reduced pressure, and the crude product was purified by flash column chromatography.
20a
Carson CA.
Kerr MA.
Angew. Chem. Int. Ed.
2006,
45:
6560 ; Angew. Chem. 2006, 118, 6710
20b
Quinkert G.
Schmalz H.-G.
Dzierzynski EM.
Dürner G.
Bats JW.
Angew. Chem., Int. Ed. Engl.
1986,
25:
992 ; Angew. Chem. 1986, 98, 1023
21
Quinkert G.
Schwartz U.
Stark H.
Weber WD.
Adam F.
Baier H.
Frank G.
Dürner G.
Liebigs Ann. Chem.
1982,
1999
22
Danishefsky S.
Rovnyak G.
J. Chem. Soc., Chem. Commun.
1972,
821
23
Hayashi T.
Yamamoto A.
Ito Y.
Tetrahedron Lett.
1988,
29:
669
24
Analytical Data for (-)-(
S
)-Dimethyl 2-Vinylcyclo-butane-1,1-dicarboxylate (
ent
-8b)
Colorless oil; [α]D
20 -154.7 [c 1.00, CHCl3; 98.8% ee (S)]. 1H NMR (500 MHz, CDCl3): δ = 1.97-2.04 (m, 1 H, CHCH
aHb), 2.06-2.19 (m, 2 H, CHCHa
H
b, CHCH2CH
aHb), 2.54-2.61 (m, 1 H, CHCH2CHa
H
b), 3.64 (ddd, J = 8.0, 8.0, 8.0 Hz, 1 H, CHCH2CH2), 3.67, 3.72 (2 s, 6 H, CO2CH3), 5.06 (dt, J = 10.2, 1.3 Hz, 1 H, CH=CH
EHZ), 5.07 (dt, J = 17.2, 1.4 Hz, 1 H, CH=CHE
H
Z), 5.82 (ddd, J = 17.1, 10.5, 6.7 Hz, 1 H, CH=CH2). 13C NMR (75 MHz, CDCl3): δ = 21.03 (t, CHCH2), 25.69 (t, CHCH2
CH2), 43.51 (d, CHCH2), 52.17, 52.47 (2 q, CO2
CH3), 57.84 [s, C(CO2CH3)2], 116.37 (t, CH=CH2), 136.42 (d, CH=CH2), 170.00, 171.90 (2 s, CO2CH3). Anal. Calcd for C10H14O4: C, 60.59; H, 7.12. Found: C, 60.46; H, 7.18. HRMS (EI): m/z calcd for C10H14O4 [M]+: 198.0892; found: 198.0890.
25
GC Data for 8a and 8b (Table 3)
Compound 8a [Chiraldex γ-Trifluoroacetyl (G-TA), 30 m × 0.25 mm × 0.125 µm, 70 °C isothermal, injector temperature 200 °C, detector temperature 250 °C]: t
R[(-)-(S)-8a] = 45 min, t
R[(+)-(R)-8a] = 54 min.
Compound 8b [Varian CP-Chirasil-Dex (β-CD), 25 m × 0.25 mm × 0.25 µm, 100 °C isothermal, injector temperature 200 °C, detector temperature 250 °C]: t
R[(-)-(S)-8b] = 16 min, t
R[(+)-(R)-8b] = 17 min.
26 The absolute configuration is as expected4b and was verified in the case of 8a by comparison of the optical rotation of (S)-8a {95.5 % ee, [α]D
20 -54.6 (c 0.98, CCl4)} with reported21 data: [α]D
25 -55.2 (c 0.98, CCl4).